Trimethyltrienolone
Trimethyltrienolone, also known by its developmental code name R-2956, is a synthetic, orally active androgen and anabolic steroid (AAS) and a derivative of nandrolone (19-nortestosterone). It is specifically a derivative of trenbolone (trienolone), a potent AAS, with the addition of three methyl groups at the R2, R17, and R18 positions. This modification significantly increases its oral bioavailability and androgenic potency, making it one of the most potent AAS known.
Pharmacology
Trimethyltrienolone binds strongly to the androgen receptor (AR), much more so than testosterone and nandrolone. Its affinity for the AR is said to be one of the highest among synthetic AAS. This high affinity is attributed to the structural modifications it has undergone, particularly the addition of methyl groups, which protect the molecule from metabolic breakdown in the liver, allowing a significant portion to enter the bloodstream intact. Its potent androgenic effects are accompanied by strong anabolic effects, though the exact ratio of androgenic to anabolic activity is not well-defined but is believed to be quite high.
Clinical Use
Despite its potent properties, trimethyltrienolone has never been marketed for medical use. Its development was likely halted due to the potential for severe hepatotoxicity (liver toxicity) and other side effects associated with its strong androgenic activity and oral bioavailability. As such, its use has been limited to scientific research, including studies on the androgen receptor and the effects of androgens on muscle and bone tissues.
Side Effects
Given its potent androgenic properties, trimethyltrienolone can cause severe side effects, particularly those related to its androgenic effects. These can include acne, hair loss, virilization in women (development of male characteristics), and an increased risk of prostate cancer in men. Additionally, its structural modifications that enhance oral bioavailability also make it potentially hepatotoxic, posing a significant risk to liver health.
Bodybuilding and Athletic Use
Like many other AAS, trimethyltrienolone has found a place in the bodybuilding and athletic communities, despite its lack of medical approval. It is prized for its potent anabolic effects, which can significantly increase muscle mass and strength. However, due to its strong androgenic effects and potential for severe liver toxicity, it is considered a high-risk substance and is not recommended for use. Its possession, sale, and use are also illegal in many countries under laws regulating controlled substances.
Legal Status
Trimethyltrienolone is classified as a controlled substance in many countries, making its non-prescribed possession, sale, or use illegal. The legal status varies by country, but it is generally included in the same categories as other potent AAS, reflecting concerns over its potential for abuse, health risks, and lack of approved medical use.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD